A new drug is giving new hope to sufferers of this form of leukemia. Sen Zhuang, M.D., Ph.D., explains the science behind it—and why he thinks cancer researchers have a lot in common with Steve Jobs.
It's been two years in the making, but the results of a pre-clinical study on an investigational therapy regimen are in. Co-author Hanneke Schuitemaker shares what researchers have learned.
Kathy Wengel, Worldwide Vice President, Supply Chain, gives an exclusive look back at her division's biggest wins over the past year—and her strategies for keeping the company competitive for years to come.
It may look deceptively simple, but this newly FDA-approved tool can help stop patients from bleeding during surgery.